PMID- 32011441 OWN - NLM STAT- MEDLINE DCOM- 20200218 LR - 20200616 IS - 1536-5964 (Electronic) IS - 0025-7974 (Print) IS - 0025-7974 (Linking) VI - 99 IP - 3 DP - 2020 Jan TI - Stretta procedure versus proton pump inhibitors for the treatment of nonerosive reflux disease: A 6-month follow-up. PG - e18610 LID - 10.1097/MD.0000000000018610 [doi] LID - e18610 AB - To compare the Stretta procedure with proton pump inhibitors for the treatment of nonerosive reflux disease (NERD).From July 2018 to April 2019, patients diagnosed with NERD and referred for treatment were enrolled. They were treated with either Stretta procedure or proton pump inhibitor (PPI) medication and followed-up for 6 months. The symptom control, quality of life, lower esophageal sphincter (LES) pressure, 24-hour pH parameters, PPI usage and satisfaction rate were evaluated. The complications were assessed. The outcomes of the 2 groups were analyzed and compared.Twenty-eight patients in the Stretta group and 21 patients in the PPI group completed the 6-month follow-up. No severe adverse events occurred in both groups. Both interventions were effective in improvement of symptom and quality of life. The symptom score improvement was significantly superior in the Stretta group compared to the PPI group (6.3 +/- 3.4 vs 8.5 +/- 4.1, P = .03). LES pressure increased significantly in the Stretta group compared to the PPI group (14.2 +/- 4.4 mm Hg vs 10.0 +/- 4.0 mm Hg, P < .01). Although both interventions improved 24-hour pH parameters, including number of acid episodes (P = .27), acid exposure time (P = .39), and DeMeester score (P = .28), no difference was found between the 2 groups. Complete PPI cessation rate (82% vs 52%, P = .03) as well as satisfaction rate (89% vs 57%, P = .02) was much higher in Stretta group than those in the PPI groupThe Stretta procedure was safe and effective in the short term for the management of NERD. The Stretta procedure resulted in higher LES pressure and achieved better improvement of symptom control and PPI cessation than did PPI in the short term. FAU - He, Suyu AU - He S AD - The Fourth Department of the Digestive Disease Center. FAU - Xu, Fei AU - Xu F AD - The Fourth Department of the Digestive Disease Center. FAU - Xiong, Xin AU - Xiong X AD - The Fourth Department of the Digestive Disease Center. FAU - Wang, Hui AU - Wang H AD - The Fourth Department of the Digestive Disease Center. FAU - Cao, Lipeng AU - Cao L AD - The Fifth Department of the Digestive Disease Center. FAU - Liang, Ninglin AU - Liang N AD - The Fourth Department of the Digestive Disease Center. FAU - Wang, Hanmei AU - Wang H AD - The Fourth Department of the Digestive Disease Center. FAU - Jing, Xiaojuan AU - Jing X AD - The Endoscopy Center, Suining Central Hospital, Sichuan, China. FAU - Liu, Tianyu AU - Liu T AD - The Fourth Department of the Digestive Disease Center. LA - eng PT - Clinical Trial PT - Journal Article PL - United States TA - Medicine (Baltimore) JT - Medicine JID - 2985248R RN - 0 (Proton Pump Inhibitors) SB - IM MH - Adult MH - Catheter Ablation/adverse effects/*methods MH - Esophageal Sphincter, Lower/physiopathology MH - Female MH - Follow-Up Studies MH - Gastroesophageal Reflux/*therapy MH - Humans MH - Hydrogen-Ion Concentration MH - Male MH - Middle Aged MH - Patient Satisfaction MH - Proton Pump Inhibitors/adverse effects/*therapeutic use MH - Quality of Life PMC - PMC7220108 COIS- The authors have no conflicts of interest to disclose. EDAT- 2020/02/06 06:00 MHDA- 2020/02/19 06:00 PMCR- 2020/01/17 CRDT- 2020/02/04 06:00 PHST- 2020/02/04 06:00 [entrez] PHST- 2020/02/06 06:00 [pubmed] PHST- 2020/02/19 06:00 [medline] PHST- 2020/01/17 00:00 [pmc-release] AID - 00005792-202001170-00012 [pii] AID - MD-D-19-05950 [pii] AID - 10.1097/MD.0000000000018610 [doi] PST - ppublish SO - Medicine (Baltimore). 2020 Jan;99(3):e18610. doi: 10.1097/MD.0000000000018610.